CHELERYTHRINE, A SELECTIVE PROTEIN-KINASE-C INHIBITOR, COUNTERACTS PYROGEN-INDUCED EXPRESSION OF TISSUE FACTOR WITHOUT EFFECT ON THROMBOMODULIN DOWN-REGULATION IN ENDOTHELIAL-CELLS
Jm. Herbert et al., CHELERYTHRINE, A SELECTIVE PROTEIN-KINASE-C INHIBITOR, COUNTERACTS PYROGEN-INDUCED EXPRESSION OF TISSUE FACTOR WITHOUT EFFECT ON THROMBOMODULIN DOWN-REGULATION IN ENDOTHELIAL-CELLS, Thrombosis research, 71(6), 1993, pp. 487-493
Endotoxin, interleukin1 beta(IL-1beta) and tumor necrosis factoralpha
(TNF-alpha) dose-dependently increased the expression of tissue factor
and at the same time induced thrombomodulin down-regulation on the su
rface of cultured bovine aortic endothelial cells. Chelerythrine, a se
lective protein kinase C inhibitor, strongly reduced endotoxin-, IL1 b
eta- and TNFalpha-induced tissue factor expression but remained withou
t effect with regard to thrombomodulin down-regulation measured in par
allel. On the contrary, staurosporine, a highly potent, non-selective
PKC inhibitor, simultaneously abolished tissue factor expression and t
hrombomodulin down-regulation induced by endotoxin, IL1beta and TNFalp
ha. These results show that protein kinase C is deeply involved in the
process leading to pyrogen-induced tissue factor expression and sugge
st that thrombomodulin down-regulation is regulated by a different pat
hway.